Cite
HARVARD Citation
Brandes, A. et al. (n.d.). A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. Neuro-oncology. 18 (8), pp. 1146-1156. [Online].